MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline GFL Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh SFL Q1 2026 Earnings Monumental EPS Surprise Overshadowed by Share Decline Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues TVGN Q4 2025 Earnings NarrowerThanExpected Loss but No Revenue Growth Keeps Stock Under Pressure